解毒剤の世界市場レポート 2025

解毒剤市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.4％で36億4,000万米ドルに成長します。予測期間の成長は、薬物過剰摂取の危機、新興毒素、規制支援、遠隔医療、遠隔診察に起因すると考えられます。予測期間の主な動向には、組み合わせ解毒剤、個別毒物管理、デジタル毒物管理、小児解毒剤が含まれます。

中毒事故の増加が、今後数年間の解毒剤市場の成長を促進すると予測されています。中毒事故は、個人が健康に有害な物質にさらされたり、摂取したり、接触したりすることで発生します。解毒剤はそのような状況において、危険な物質の有害な影響を打ち消すために不可欠です。これらの解毒剤は、毒物の有害な影響を中和、緩和、逆転させます。例えば、2023年10月、米国を拠点とする多国籍ニュースチャンネル、ケーブルニュースネットワーク（CNN）の報告によると、2023年5月の過剰摂取による死亡者数は112,024人で、2022年5月の109,261人から2.5％増加しました。したがって、中毒事故の増加が解毒剤市場の拡大を促進しています。

病態の有病率の増加は、解毒剤市場の成長を促進すると予想されます。オピオイド中毒、シアン化物中毒、ベンゾジアゼピン中毒などの病状は、身体の構造や機能に悪影響を及ぼし、解毒剤で治療や予防が可能です。これらの解毒剤は、毒に結合し、中和し、体への有害な影響をブロックすることによって機能します。例えば、2023年12月、米国を拠点とする多国籍医療保険・サービス会社UnitedHealth Group Incorporatedは、成人の糖尿病有病率が11.5%に急増し、3,190万人の成人が影響を受けていると報告し、うつ病有病率は21.7%に増加し、5,420万人の成人が影響を受けていると報告しました。従って、有病率の上昇が解毒剤市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界解毒剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の解毒剤市場：成長率分析
• 世界の解毒剤市場の実績：規模と成長, 2019-2024
• 世界の解毒剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界解毒剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の解毒剤市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学解毒剤
• 物理的な解毒剤
• 薬理学解毒剤
• その他のタイプ
• 世界の解毒剤市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射可能
• オーラル
• カプセルと錠剤
• シロップ
• 世界の解毒剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物に噛まれた
• 重金属中毒
• 世界の解毒剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界の解毒剤市場化学解毒剤の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• キレート剤
• 酸化剤
• 還元剤
• 世界の解毒剤市場、物理的解毒剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 活性炭
• 胃洗浄
• 全腸洗浄
• 世界の解毒剤市場、薬理学的解毒剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• オピオイド拮抗薬
• ベンゾジアゼピン拮抗薬
• コリンエステラーゼ再活性化剤
• 世界の解毒剤市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 支持療法
• 補助治療

第7章 地域別・国別分析

• 世界の解毒剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の解毒剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 解毒剤市場：競合情勢
• 解毒剤市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bristol Myers Squibb
• Alexion Pharmaceuticals Inc.
• AstraZeneca plc
• Sanofi S.A.
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• CSL Behring
• Daiichi Sanko Inc.
• Fresenius Kabi AG
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories Ltd.
• Hikma Pharmaceuticals plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 解毒剤市場2029：新たな機会を提供する国
• 解毒剤市場2029：新たな機会を提供するセグメント
• 解毒剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Antidotes are substances or therapeutic interventions developed to counter and alleviate the harmful effects of poisons or toxic substances within the body, with the aim of mitigating or neutralizing the toxic impact of these substances.

Antidotes come in several types, including chemical antidotes, physical antidotes, pharmacological antidotes, and others. Chemical antidotes are substances or compounds specifically formulated to counteract the toxic effects of particular chemical substances or poisons. They are employed in situations where exposure to a harmful substance has occurred, with the objective of neutralizing, mitigating, or reversing the toxic effects. These chemical antidotes can be administered through various forms, such as injectables, oral medications, capsules, tablets, and syrups. They find applications in diverse scenarios, including the treatment of animal bites and heavy metal poisoning, and are typically administered by healthcare providers in hospitals, homecare settings, specialty clinics, and other relevant healthcare facilities.

The antidotes market research report is one of a series of new reports from The Business Research Company that provides antidotes market statistics, including antidotes industry global market size, regional shares, competitors with an antidotes market share, detailed antidotes market segments, market trends and opportunities and any further data you may need to thrive in the antidotes industry. This antidotes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antidotes market size has grown strongly in recent years. It will grow from $2.23 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to poison control centers, regulatory approvals, industrial and occupational safety, education and training.

The antidotes market size is expected to see rapid growth in the next few years. It will grow to $3.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to drug overdose crisis, emerging toxins, regulatory support, telemedicine and remote consultation. Major trends in the forecast period include combination antidotes, personalized poison management, digital poison control, pediatric antidotes.

An increase in poisoning incidents is expected to drive the growth of the antidotes market in the coming years. Poisoning incidents occur when individuals are exposed to, ingest, or come into contact with substances that are toxic to their health. Antidotes are vital in such situations as they counteract the harmful effects of dangerous substances. These antidotes neutralize, mitigate, or reverse the damaging impacts of poisons. For example, in October 2023, a report from Cable News Network (CNN), a U.S.-based multinational news channel, stated that there were 112,024 overdose deaths in May 2023, a 2.5% increase from 109,261 in May 2022. Hence, the rise in poisoning incidents is driving the expansion of the antidotes market.

The growing prevalence of medical conditions is expected to propel the growth of the antidotes market. Medical conditions such as opioid poisoning, cyanide poisoning, or benzodiazepine poisoning negatively impact the structure or function of the body and can be treated or prevented with antidotes. These antidotes work by binding to the poison, neutralizing it, or blocking its harmful effects on the body. For instance, in December 2023, UnitedHealth Group Incorporated, a U.S.-based multinational health insurance and services company, reported that the prevalence of diabetes among adults surged to 11.5%, affecting 31.9 million adults, while the prevalence of depression increased to 21.7%, impacting 54.2 million adults. Therefore, the rising prevalence of medical conditions is driving the growth of the antidotes market.

Prominent market players are dedicating their efforts to introduce innovative products like atropine sulfate injections to extend their market presence and provide enhanced treatment alternatives. Atropine sulfate injection is a type of antimuscarinic medication designed to inhibit the action of acetylcholine at muscarinic receptors within the parasympathetic nervous system. For instance, in August 2022, American Regent Inc., a US-based pharmaceutical company specializing in sterile injectables for healthcare providers, launched an atropine sulfate injection, USP. This traditional injectable medication is used as an antisialagogue, an antidote for organophosphorus poisoning or muscarinic mushroom poisoning, and to treat bradyasystolic cardiac arrest. Its primary purpose is to temporarily block severe or life-threatening muscarinic effects.

In July 2022, Soligenix Inc., a US-based biopharmaceutical company, established a partnership with SERB Pharmaceuticals to develop a novel ricin antigen for the treatment of ricin toxin poisoning. This collaboration aims to create a medical solution for ricin toxin poisoning. It combines Soligenix's antigen expertise with SERB Pharmaceuticals' proficiency in antibody research and manufacturing. SERB Pharmaceuticals, based in France, specializes in emergency care and is dedicated to developing and providing antidotes for critical conditions.

Major companies operating in the antidotes market are Pfizer Inc., Johnson & Johnson, Merck & Co., Bayer AG, Novartis AG, Bristol Myers Squibb, Alexion Pharmaceuticals Inc., AstraZeneca PLC, Sanofi S.A., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., CSL Behring, Daiichi Sanko Inc., Fresenius Kabi AG, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Ferring B.V., Lupin Limited, Zydus Lifesciences Ltd., Mallinckrodt Pharmaceuticals Ltd., Nichi-Iko Pharmaceutical Co. Ltd., Akorn Incorporated, Meridian Medical Technologies Inc., Alvogen Pharma India Pvt. Ltd., Wockhardt Limited, ADAPT Pharma Inc.

North America was the largest region in the antidotes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antidotes report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antidotes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antidotes market consists of sales of opioid antidotes, anticholinergic antidotes, benzodiazepine antidotes, anticoagulant antidotes, iron chelators, cyanide antidotes, heavy metal antidotes and digoxin antidotes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antidotes Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antidotes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antidotes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antidotes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Chemical Antidotes; Physical Antidotes; Pharmacological Antidotes; Other Types
• 2) By Route Of Administration: Injectable; Oral; Capsules And Tablets; Syrup
• 3) By Application: Animal Bites; Heavy Metal Poisoning
• 4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Chemical Antidotes: Chelating Agents; Oxidizing Agents; Reducing Agents
• 2) By Physical Antidotes: Activated Charcoal; Gastric Lavage; Whole Bowel Irrigation
• 3) By Pharmacological Antidotes: Opioid Antagonists; Benzodiazepine Antagonists; Cholinesterase Reactivators
• 4) By Other Types: Supportive Therapies; Adjunctive Treatments
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antidotes Market Characteristics

3. Antidotes Market Trends And Strategies

4. Antidotes Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Antidotes Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antidotes PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antidotes Market Growth Rate Analysis
• 5.4. Global Antidotes Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antidotes Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antidotes Total Addressable Market (TAM)

6. Antidotes Market Segmentation

• 6.1. Global Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Antidotes
• Physical Antidotes
• Pharmacological Antidotes
• Other Types
• 6.2. Global Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable
• Oral
• Capsules And Tablets
• Syrup
• 6.3. Global Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Animal Bites
• Heavy Metal Poisoning
• 6.4. Global Antidotes Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.5. Global Antidotes Market, Sub-Segmentation Of Chemical Antidotes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chelating Agents
• Oxidizing Agents
• Reducing Agents
• 6.6. Global Antidotes Market, Sub-Segmentation Of Physical Antidotes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Activated Charcoal
• Gastric Lavage
• Whole Bowel Irrigation
• 6.7. Global Antidotes Market, Sub-Segmentation Of Pharmacological Antidotes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Opioid Antagonists
• Benzodiazepine Antagonists
• Cholinesterase Reactivators
• 6.8. Global Antidotes Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Supportive Therapies
• Adjunctive Treatments

7. Antidotes Market Regional And Country Analysis

• 7.1. Global Antidotes Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antidotes Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antidotes Market

• 8.1. Asia-Pacific Antidotes Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antidotes Market

• 9.1. China Antidotes Market Overview
• 9.2. China Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antidotes Market

• 10.1. India Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antidotes Market

• 11.1. Japan Antidotes Market Overview
• 11.2. Japan Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antidotes Market

• 12.1. Australia Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antidotes Market

• 13.1. Indonesia Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antidotes Market

• 14.1. South Korea Antidotes Market Overview
• 14.2. South Korea Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antidotes Market

• 15.1. Western Europe Antidotes Market Overview
• 15.2. Western Europe Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antidotes Market

• 16.1. UK Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antidotes Market

• 17.1. Germany Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antidotes Market

• 18.1. France Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antidotes Market

• 19.1. Italy Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antidotes Market

• 20.1. Spain Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antidotes Market

• 21.1. Eastern Europe Antidotes Market Overview
• 21.2. Eastern Europe Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antidotes Market

• 22.1. Russia Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antidotes Market

• 23.1. North America Antidotes Market Overview
• 23.2. North America Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antidotes Market

• 24.1. USA Antidotes Market Overview
• 24.2. USA Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antidotes Market

• 25.1. Canada Antidotes Market Overview
• 25.2. Canada Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antidotes Market

• 26.1. South America Antidotes Market Overview
• 26.2. South America Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antidotes Market

• 27.1. Brazil Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antidotes Market

• 28.1. Middle East Antidotes Market Overview
• 28.2. Middle East Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antidotes Market

• 29.1. Africa Antidotes Market Overview
• 29.2. Africa Antidotes Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antidotes Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antidotes Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antidotes Market Competitive Landscape And Company Profiles

• 30.1. Antidotes Market Competitive Landscape
• 30.2. Antidotes Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Antidotes Market Other Major And Innovative Companies

• 31.1. Bristol Myers Squibb
• 31.2. Alexion Pharmaceuticals Inc.
• 31.3. AstraZeneca plc
• 31.4. Sanofi S.A.
• 31.5. Eli Lilly and Company
• 31.6. Boehringer Ingelheim International GmbH
• 31.7. Baxter International Inc.
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Mylan N.V.
• 31.10. CSL Behring
• 31.11. Daiichi Sanko Inc.
• 31.12. Fresenius Kabi AG
• 31.13. Aurobindo Pharma Limited
• 31.14. Dr. Reddy's Laboratories Ltd.
• 31.15. Hikma Pharmaceuticals plc

32. Global Antidotes Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antidotes Market

34. Recent Developments In The Antidotes Market

35. Antidotes Market High Potential Countries, Segments and Strategies

• 35.1 Antidotes Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antidotes Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antidotes Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer